Selected research
Industry Research
Plant-based Soft Capsules (Softgel) Industry Research Report 2026
Market perspective
The global Plant-based Soft Capsules (Softgel) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Plant-based Soft Capsules (Softgel) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Plant-based Soft Capsules (Softgel) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Plant-based Soft Capsules (Softgel) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Plant-based Soft Capsules (Softgel) include Catalent, Procaps Laboratorios, Eurocaps, Sirio Pharma (Best Formulations), Aenova, Captek, Bahrain Pharma, Robinson Pharma and Aland, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Plant-based Soft Capsules (Softgel) market in terms of revenue (US$ million) and, where applicable, sales volume (units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plant-based Soft Capsules (Softgel) Market by Company
Catalent
Procaps Laboratorios
Eurocaps
Sirio Pharma (Best Formulations)
Aenova
Captek
Bahrain Pharma
Robinson Pharma
Aland
Fuji Capsule
Sunsho Pharmaceutical
Erkang
Baihe Group
Plant-based Soft Capsules (Softgel) Segment by Type
Carrageenan
Starch
Gellan Gum
Plant-based Soft Capsules (Softgel) Segment by Application
Rx and OTC
Supplements
Other
Plant-based Soft Capsules (Softgel) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plant-based Soft Capsules (Softgel) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plant-based Soft Capsules (Softgel) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plant-based Soft Capsules (Softgel).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Plant-based Soft Capsules (Softgel) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Plant-based Soft Capsules (Softgel) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Plant-based Soft Capsules (Softgel) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Carrageenan
- Starch
- Gellan Gum
Applications
- Rx and OTC
- Supplements
- Other
Companies covered
- Catalent
- Procaps Laboratorios
- Eurocaps
- Sirio Pharma (Best Formulations)
- Aenova
- Captek
- Bahrain Pharma
- Robinson Pharma
- Aland
- Fuji Capsule
- Sunsho Pharmaceutical
- Erkang
- Baihe Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Plant-based Soft Capsules (Softgel) Market Size (2021-2032)
- 2.2.2 Global Plant-based Soft Capsules (Softgel) Sales (2021-2032)
- 2.2.3 Global Plant-based Soft Capsules (Softgel) Market Average Price (2021-2032)
- 2.3 Plant-based Soft Capsules (Softgel) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Carrageenan
- 2.3.3 Starch
- 2.3.4 Gellan Gum
- 2.4 Plant-based Soft Capsules (Softgel) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Rx and OTC
- 2.4.3 Supplements
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Plant-based Soft Capsules (Softgel) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Plant-based Soft Capsules (Softgel) Sales (units) of Manufacturers (2021-2026)
- 3.3 Global Plant-based Soft Capsules (Softgel) Revenue of Manufacturers (2021-2026)
- 3.4 Global Plant-based Soft Capsules (Softgel) Average Price by Manufacturers (2021-2026)
- 3.5 Global Plant-based Soft Capsules (Softgel) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Plant-based Soft Capsules (Softgel), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Plant-based Soft Capsules (Softgel), Product Type & Application
- 3.8 Global Manufacturers of Plant-based Soft Capsules (Softgel), Established Date
- 3.9 Global Plant-based Soft Capsules (Softgel) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Catalent
- 4.1.1 Catalent Company Information
- 4.1.2 Catalent Business Overview
- 4.1.3 Catalent Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Catalent Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.1.5 Catalent Recent Developments
- 4.2 Procaps Laboratorios
- 4.2.1 Procaps Laboratorios Company Information
- 4.2.2 Procaps Laboratorios Business Overview
- 4.2.3 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Procaps Laboratorios Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.2.5 Procaps Laboratorios Recent Developments
- 4.3 Eurocaps
- 4.3.1 Eurocaps Company Information
- 4.3.2 Eurocaps Business Overview
- 4.3.3 Eurocaps Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eurocaps Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.3.5 Eurocaps Recent Developments
- 4.4 Sirio Pharma (Best Formulations)
- 4.4.1 Sirio Pharma (Best Formulations) Company Information
- 4.4.2 Sirio Pharma (Best Formulations) Business Overview
- 4.4.3 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sirio Pharma (Best Formulations) Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.4.5 Sirio Pharma (Best Formulations) Recent Developments
- 4.5 Aenova
- 4.5.1 Aenova Company Information
- 4.5.2 Aenova Business Overview
- 4.5.3 Aenova Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Aenova Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.5.5 Aenova Recent Developments
- 4.6 Captek
- 4.6.1 Captek Company Information
- 4.6.2 Captek Business Overview
- 4.6.3 Captek Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Captek Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.6.5 Captek Recent Developments
- 4.7 Bahrain Pharma
- 4.7.1 Bahrain Pharma Company Information
- 4.7.2 Bahrain Pharma Business Overview
- 4.7.3 Bahrain Pharma Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bahrain Pharma Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.7.5 Bahrain Pharma Recent Developments
- 4.8 Robinson Pharma
- 4.8.1 Robinson Pharma Company Information
- 4.8.2 Robinson Pharma Business Overview
- 4.8.3 Robinson Pharma Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Robinson Pharma Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.8.5 Robinson Pharma Recent Developments
- 4.9 Aland
- 4.9.1 Aland Company Information
- 4.9.2 Aland Business Overview
- 4.9.3 Aland Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Aland Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.9.5 Aland Recent Developments
- 4.10 Fuji Capsule
- 4.10.1 Fuji Capsule Company Information
- 4.10.2 Fuji Capsule Business Overview
- 4.10.3 Fuji Capsule Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Fuji Capsule Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.10.5 Fuji Capsule Recent Developments
- 4.11 Sunsho Pharmaceutical
- 4.11.1 Sunsho Pharmaceutical Company Information
- 4.11.2 Sunsho Pharmaceutical Business Overview
- 4.11.3 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sunsho Pharmaceutical Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.11.5 Sunsho Pharmaceutical Recent Developments
- 4.12 Erkang
- 4.12.1 Erkang Company Information
- 4.12.2 Erkang Business Overview
- 4.12.3 Erkang Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Erkang Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.12.5 Erkang Recent Developments
- 4.13 Baihe Group
- 4.13.1 Baihe Group Company Information
- 4.13.2 Baihe Group Business Overview
- 4.13.3 Baihe Group Plant-based Soft Capsules (Softgel) Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Baihe Group Plant-based Soft Capsules (Softgel) Product Portfolio
- 4.13.5 Baihe Group Recent Developments
5 Global Plant-based Soft Capsules (Softgel) Market Scenario by Region
- 5.1 Global Plant-based Soft Capsules (Softgel) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021-2032
- 5.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Region: 2021-2026
- 5.2.2 Global Plant-based Soft Capsules (Softgel) Sales by Region: 2027-2032
- 5.3 Global Plant-based Soft Capsules (Softgel) Revenue by Region: 2021-2032
- 5.3.1 Global Plant-based Soft Capsules (Softgel) Revenue by Region: 2021-2026
- 5.3.2 Global Plant-based Soft Capsules (Softgel) Revenue by Region: 2027-2032
- 5.4 North America Plant-based Soft Capsules (Softgel) Market Facts & Figures by Country
- 5.4.1 North America Plant-based Soft Capsules (Softgel) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 5.4.3 North America Plant-based Soft Capsules (Softgel) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Plant-based Soft Capsules (Softgel) Market Facts & Figures by Country
- 5.5.1 Europe Plant-based Soft Capsules (Softgel) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 5.5.3 Europe Plant-based Soft Capsules (Softgel) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Plant-based Soft Capsules (Softgel) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Plant-based Soft Capsules (Softgel) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Plant-based Soft Capsules (Softgel) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Plant-based Soft Capsules (Softgel) Market Facts & Figures by Country
- 5.7.1 South America Plant-based Soft Capsules (Softgel) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 5.7.3 South America Plant-based Soft Capsules (Softgel) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Plant-based Soft Capsules (Softgel) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Plant-based Soft Capsules (Softgel) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Plant-based Soft Capsules (Softgel) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Plant-based Soft Capsules (Softgel) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Plant-based Soft Capsules (Softgel) Sales by Type (2021-2032)
- 6.1.1 Global Plant-based Soft Capsules (Softgel) Sales by Type (2021-2032) & (units)
- 6.1.2 Global Plant-based Soft Capsules (Softgel) Sales Market Share by Type (2021-2032)
- 6.2 Global Plant-based Soft Capsules (Softgel) Revenue by Type (2021-2032)
- 6.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Plant-based Soft Capsules (Softgel) Revenue Market Share by Type (2021-2032)
- 6.3 Global Plant-based Soft Capsules (Softgel) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Plant-based Soft Capsules (Softgel) Sales by Application (2021-2032)
- 7.1.1 Global Plant-based Soft Capsules (Softgel) Sales by Application (2021-2032) & (units)
- 7.1.2 Global Plant-based Soft Capsules (Softgel) Sales Market Share by Application (2021-2032)
- 7.2 Global Plant-based Soft Capsules (Softgel) Revenue by Application (2021-2032)
- 7.2.1 Global Plant-based Soft Capsules (Softgel) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Plant-based Soft Capsules (Softgel) Revenue Market Share by Application (2021-2032)
- 7.3 Global Plant-based Soft Capsules (Softgel) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Plant-based Soft Capsules (Softgel) Value Chain Analysis
- 8.1.1 Plant-based Soft Capsules (Softgel) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Plant-based Soft Capsules (Softgel) Production Mode & Process
- 8.2 Plant-based Soft Capsules (Softgel) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Plant-based Soft Capsules (Softgel) Distributors
- 8.2.3 Plant-based Soft Capsules (Softgel) Customers
9 Global Plant-based Soft Capsules (Softgel) Analyzing Market Dynamics
- 9.1 Plant-based Soft Capsules (Softgel) Industry Trends
- 9.2 Plant-based Soft Capsules (Softgel) Industry Drivers
- 9.3 Plant-based Soft Capsules (Softgel) Industry Opportunities and Challenges
- 9.4 Plant-based Soft Capsules (Softgel) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst